 | • レポートコード：MRC2-11QY00429 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は複合ホルモン避妊薬のグローバル市場について調査・分析したレポートです。種類別（ピル、パッチ、リング）市場規模、用途別（病院薬局、小売薬局、Eコマース、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別複合ホルモン避妊薬の競争状況、市場シェア ・世界の複合ホルモン避妊薬市場：種類別市場規模 2015年-2020年（ピル、パッチ、リング） ・世界の複合ホルモン避妊薬市場：種類別市場規模予測 2021年-2026年（ピル、パッチ、リング） ・世界の複合ホルモン避妊薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、Eコマース、その他） ・世界の複合ホルモン避妊薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、Eコマース、その他） ・北米の複合ホルモン避妊薬市場分析：米国、カナダ ・ヨーロッパの複合ホルモン避妊薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの複合ホルモン避妊薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の複合ホルモン避妊薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの複合ホルモン避妊薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva Pharmaceutical Industries、Bayer HealthCare Pharmaceuticals、Actavis、Pfizer、Johnson & Johnson、GlaxoSmithKline、Watson Pharma、Cipla、Novartis International ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregnancies. Combined hormonal contraceptives are one of the effective contraceptives in modern medicine. Since late 1950s variety of innovation has been developed to improve the efficacy and safety of combined hormonal contraceptive. The trends have been shifted towards less androgenic progestogens and lower doses of estrogen and progestogen. Changing in drug doses and modification in drug component with the incorporation of new technologies that can reduce the risk factor and the continuing development of novel delivery systems that can be helpful to fulfill unmet needs of the market. The other health benefits of combined hormonal contraceptives include they reduce the risk of iron deficiency anemia, endometriosis, used in treating acne vulgaris, irregular menstrual flow, and polycystic ovarian syndrome. The mechanism of combined hormonal contraceptive is inhibition of follicle stimulating hormone and luteinizing hormone. Ethinylestradiol is the most common estrogen used in combined hormonal contraceptives, whereas other hormones are also used. The combined hormonal contraceptive products are available in various forms whereas pills have the maximum share in the combined hormonal contraceptive market. According to the Association of Women Health, around 100 million women use combined hormonal contraceptives throughout the world.
The growth of the combined hormonal contraceptive market is driven by growing predominance and more productive medications with emerging interest in quick substitutes. Reduction in the cost of hospitalization and high efficacy can be the prime driving factors for the growth of the combined hormonal contraceptive market over the forecast period. In emerging countries, the adoption of combined hormonal contraceptives has increased, along with increasing health consciousness and awareness. Growing menstruating population worldwide and various initiatives taken by the governments, such as birth control and women health awareness programs, are factors expected to increase the usage of combined hormonal contraceptive products globally. Strategic collaborations and acquisitions among manufacturers are also expected to boost the growth of the combined hormonal contraceptive market. However, side effects related to the combined hormonal contraceptive products can hamper the growth of the combined hormonal contraceptive market.
Market Analysis and Insights: Global Combined hormonal contraceptive Market
The global Combined hormonal contraceptive market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Combined hormonal contraceptive Scope and Market Size
Combined hormonal contraceptive market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Combined hormonal contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Combined hormonal contraceptive market is segmented into
Pills
Patch
Ring
Segment by Application, the Combined hormonal contraceptive market is segmented into
Hospital Pharmacies
Retail Pharmacies
E-commerce
Others
Regional and Country-level Analysis
The Combined hormonal contraceptive market is analysed and market size information is provided by regions (countries).
The key regions covered in the Combined hormonal contraceptive market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Combined hormonal contraceptive Market Share Analysis
Combined hormonal contraceptive market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Combined hormonal contraceptive business, the date to enter into the Combined hormonal contraceptive market, Combined hormonal contraceptive product introduction, recent developments, etc.
The major vendors covered:
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Watson Pharma
Cipla
Novartis International
1 Study Coverage
1.1 Combined hormonal contraceptive Product Introduction
1.2 Market Segments
1.3 Key Combined hormonal contraceptive Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Combined hormonal contraceptive Market Size Growth Rate by Type
1.4.2 Pills
1.4.3 Patch
1.4.4 Ring
1.5 Market by Application
1.5.1 Global Combined hormonal contraceptive Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 E-commerce
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Combined hormonal contraceptive Market Size, Estimates and Forecasts
2.1.1 Global Combined hormonal contraceptive Revenue 2015-2026
2.1.2 Global Combined hormonal contraceptive Sales 2015-2026
2.2 Global Combined hormonal contraceptive, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Combined hormonal contraceptive Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Combined hormonal contraceptive Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Combined hormonal contraceptive Competitor Landscape by Players
3.1 Combined hormonal contraceptive Sales by Manufacturers
3.1.1 Combined hormonal contraceptive Sales by Manufacturers (2015-2020)
3.1.2 Combined hormonal contraceptive Sales Market Share by Manufacturers (2015-2020)
3.2 Combined hormonal contraceptive Revenue by Manufacturers
3.2.1 Combined hormonal contraceptive Revenue by Manufacturers (2015-2020)
3.2.2 Combined hormonal contraceptive Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Combined hormonal contraceptive Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Combined hormonal contraceptive Revenue in 2019
3.2.5 Global Combined hormonal contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Combined hormonal contraceptive Price by Manufacturers
3.4 Combined hormonal contraceptive Manufacturing Base Distribution, Product Types
3.4.1 Combined hormonal contraceptive Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Combined hormonal contraceptive Product Type
3.4.3 Date of International Manufacturers Enter into Combined hormonal contraceptive Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Combined hormonal contraceptive Market Size by Type (2015-2020)
4.1.1 Global Combined hormonal contraceptive Sales by Type (2015-2020)
4.1.2 Global Combined hormonal contraceptive Revenue by Type (2015-2020)
4.1.3 Combined hormonal contraceptive Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Combined hormonal contraceptive Market Size Forecast by Type (2021-2026)
4.2.1 Global Combined hormonal contraceptive Sales Forecast by Type (2021-2026)
4.2.2 Global Combined hormonal contraceptive Revenue Forecast by Type (2021-2026)
4.2.3 Combined hormonal contraceptive Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Combined hormonal contraceptive Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Combined hormonal contraceptive Market Size by Application (2015-2020)
5.1.1 Global Combined hormonal contraceptive Sales by Application (2015-2020)
5.1.2 Global Combined hormonal contraceptive Revenue by Application (2015-2020)
5.1.3 Combined hormonal contraceptive Price by Application (2015-2020)
5.2 Combined hormonal contraceptive Market Size Forecast by Application (2021-2026)
5.2.1 Global Combined hormonal contraceptive Sales Forecast by Application (2021-2026)
5.2.2 Global Combined hormonal contraceptive Revenue Forecast by Application (2021-2026)
5.2.3 Global Combined hormonal contraceptive Price Forecast by Application (2021-2026)
6 North America
6.1 North America Combined hormonal contraceptive by Country
6.1.1 North America Combined hormonal contraceptive Sales by Country
6.1.2 North America Combined hormonal contraceptive Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Combined hormonal contraceptive Market Facts & Figures by Type
6.3 North America Combined hormonal contraceptive Market Facts & Figures by Application
7 Europe
7.1 Europe Combined hormonal contraceptive by Country
7.1.1 Europe Combined hormonal contraceptive Sales by Country
7.1.2 Europe Combined hormonal contraceptive Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Combined hormonal contraceptive Market Facts & Figures by Type
7.3 Europe Combined hormonal contraceptive Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Combined hormonal contraceptive by Region
8.1.1 Asia Pacific Combined hormonal contraceptive Sales by Region
8.1.2 Asia Pacific Combined hormonal contraceptive Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Combined hormonal contraceptive Market Facts & Figures by Type
8.3 Asia Pacific Combined hormonal contraceptive Market Facts & Figures by Application
9 Latin America
9.1 Latin America Combined hormonal contraceptive by Country
9.1.1 Latin America Combined hormonal contraceptive Sales by Country
9.1.2 Latin America Combined hormonal contraceptive Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Combined hormonal contraceptive Market Facts & Figures by Type
9.3 Central & South America Combined hormonal contraceptive Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Combined hormonal contraceptive by Country
10.1.1 Middle East and Africa Combined hormonal contraceptive Sales by Country
10.1.2 Middle East and Africa Combined hormonal contraceptive Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Combined hormonal contraceptive Market Facts & Figures by Type
10.3 Middle East and Africa Combined hormonal contraceptive Market Facts & Figures by Application
11 Company Profiles
11.1 Teva Pharmaceutical Industries
11.1.1 Teva Pharmaceutical Industries Corporation Information
11.1.2 Teva Pharmaceutical Industries Description and Business Overview
11.1.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Pharmaceutical Industries Combined hormonal contraceptive Products Offered
11.1.5 Teva Pharmaceutical Industries Related Developments
11.2 Bayer HealthCare Pharmaceuticals
11.2.1 Bayer HealthCare Pharmaceuticals Corporation Information
11.2.2 Bayer HealthCare Pharmaceuticals Description and Business Overview
11.2.3 Bayer HealthCare Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Products Offered
11.2.5 Bayer HealthCare Pharmaceuticals Related Developments
11.3 Actavis
11.3.1 Actavis Corporation Information
11.3.2 Actavis Description and Business Overview
11.3.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Actavis Combined hormonal contraceptive Products Offered
11.3.5 Actavis Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Combined hormonal contraceptive Products Offered
11.4.5 Pfizer Related Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Description and Business Overview
11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Johnson & Johnson Combined hormonal contraceptive Products Offered
11.5.5 Johnson & Johnson Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Combined hormonal contraceptive Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 Watson Pharma
11.7.1 Watson Pharma Corporation Information
11.7.2 Watson Pharma Description and Business Overview
11.7.3 Watson Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Watson Pharma Combined hormonal contraceptive Products Offered
11.7.5 Watson Pharma Related Developments
11.8 Cipla
11.8.1 Cipla Corporation Information
11.8.2 Cipla Description and Business Overview
11.8.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Cipla Combined hormonal contraceptive Products Offered
11.8.5 Cipla Related Developments
11.9 Novartis International
11.9.1 Novartis International Corporation Information
11.9.2 Novartis International Description and Business Overview
11.9.3 Novartis International Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Novartis International Combined hormonal contraceptive Products Offered
11.9.5 Novartis International Related Developments
11.1 Teva Pharmaceutical Industries
11.1.1 Teva Pharmaceutical Industries Corporation Information
11.1.2 Teva Pharmaceutical Industries Description and Business Overview
11.1.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Pharmaceutical Industries Combined hormonal contraceptive Products Offered
11.1.5 Teva Pharmaceutical Industries Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Combined hormonal contraceptive Market Estimates and Projections by Region
12.1.1 Global Combined hormonal contraceptive Sales Forecast by Regions 2021-2026
12.1.2 Global Combined hormonal contraceptive Revenue Forecast by Regions 2021-2026
12.2 North America Combined hormonal contraceptive Market Size Forecast (2021-2026)
12.2.1 North America: Combined hormonal contraceptive Sales Forecast (2021-2026)
12.2.2 North America: Combined hormonal contraceptive Revenue Forecast (2021-2026)
12.2.3 North America: Combined hormonal contraceptive Market Size Forecast by Country (2021-2026)
12.3 Europe Combined hormonal contraceptive Market Size Forecast (2021-2026)
12.3.1 Europe: Combined hormonal contraceptive Sales Forecast (2021-2026)
12.3.2 Europe: Combined hormonal contraceptive Revenue Forecast (2021-2026)
12.3.3 Europe: Combined hormonal contraceptive Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Combined hormonal contraceptive Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Combined hormonal contraceptive Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Combined hormonal contraceptive Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Combined hormonal contraceptive Market Size Forecast by Region (2021-2026)
12.5 Latin America Combined hormonal contraceptive Market Size Forecast (2021-2026)
12.5.1 Latin America: Combined hormonal contraceptive Sales Forecast (2021-2026)
12.5.2 Latin America: Combined hormonal contraceptive Revenue Forecast (2021-2026)
12.5.3 Latin America: Combined hormonal contraceptive Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Combined hormonal contraceptive Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Combined hormonal contraceptive Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Combined hormonal contraceptive Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Combined hormonal contraceptive Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Combined hormonal contraceptive Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Combined hormonal contraceptive Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Combined hormonal contraceptive Market Segments
Table 2. Ranking of Global Top Combined hormonal contraceptive Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Combined hormonal contraceptive Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Pills
Table 5. Major Manufacturers of Patch
Table 6. Major Manufacturers of Ring
Table 7. Global Combined hormonal contraceptive Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Combined hormonal contraceptive Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Combined hormonal contraceptive Sales by Regions 2015-2020 (K MT)
Table 10. Global Combined hormonal contraceptive Sales Market Share by Regions (2015-2020)
Table 11. Global Combined hormonal contraceptive Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Combined hormonal contraceptive Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Combined hormonal contraceptive Sales Share by Manufacturers (2015-2020)
Table 14. Global Combined hormonal contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Combined hormonal contraceptive by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Combined hormonal contraceptive as of 2019)
Table 16. Combined hormonal contraceptive Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Combined hormonal contraceptive Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Combined hormonal contraceptive Price (2015-2020) (USD/MT)
Table 19. Combined hormonal contraceptive Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Combined hormonal contraceptive Product Type
Table 21. Date of International Manufacturers Enter into Combined hormonal contraceptive Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Combined hormonal contraceptive Sales by Type (2015-2020) (K MT)
Table 24. Global Combined hormonal contraceptive Sales Share by Type (2015-2020)
Table 25. Global Combined hormonal contraceptive Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Combined hormonal contraceptive Revenue Share by Type (2015-2020)
Table 27. Combined hormonal contraceptive Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Combined hormonal contraceptive Sales by Application (2015-2020) (K MT)
Table 29. Global Combined hormonal contraceptive Sales Share by Application (2015-2020)
Table 30. North America Combined hormonal contraceptive Sales by Country (2015-2020) (K MT)
Table 31. North America Combined hormonal contraceptive Sales Market Share by Country (2015-2020)
Table 32. North America Combined hormonal contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Combined hormonal contraceptive Revenue Market Share by Country (2015-2020)
Table 34. North America Combined hormonal contraceptive Sales by Type (2015-2020) (K MT)
Table 35. North America Combined hormonal contraceptive Sales Market Share by Type (2015-2020)
Table 36. North America Combined hormonal contraceptive Sales by Application (2015-2020) (K MT)
Table 37. North America Combined hormonal contraceptive Sales Market Share by Application (2015-2020)
Table 38. Europe Combined hormonal contraceptive Sales by Country (2015-2020) (K MT)
Table 39. Europe Combined hormonal contraceptive Sales Market Share by Country (2015-2020)
Table 40. Europe Combined hormonal contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Combined hormonal contraceptive Revenue Market Share by Country (2015-2020)
Table 42. Europe Combined hormonal contraceptive Sales by Type (2015-2020) (K MT)
Table 43. Europe Combined hormonal contraceptive Sales Market Share by Type (2015-2020)
Table 44. Europe Combined hormonal contraceptive Sales by Application (2015-2020) (K MT)
Table 45. Europe Combined hormonal contraceptive Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Combined hormonal contraceptive Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Combined hormonal contraceptive Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Combined hormonal contraceptive Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Combined hormonal contraceptive Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Combined hormonal contraceptive Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Combined hormonal contraceptive Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Combined hormonal contraceptive Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Combined hormonal contraceptive Sales Market Share by Application (2015-2020)
Table 54. Latin America Combined hormonal contraceptive Sales by Country (2015-2020) (K MT)
Table 55. Latin America Combined hormonal contraceptive Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Combined hormonal contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Combined hormonal contraceptive Revenue Market Share by Country (2015-2020)
Table 58. Latin America Combined hormonal contraceptive Sales by Type (2015-2020) (K MT)
Table 59. Latin America Combined hormonal contraceptive Sales Market Share by Type (2015-2020)
Table 60. Latin America Combined hormonal contraceptive Sales by Application (2015-2020) (K MT)
Table 61. Latin America Combined hormonal contraceptive Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Combined hormonal contraceptive Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Combined hormonal contraceptive Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Combined hormonal contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Combined hormonal contraceptive Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Combined hormonal contraceptive Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Combined hormonal contraceptive Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Combined hormonal contraceptive Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Combined hormonal contraceptive Sales Market Share by Application (2015-2020)
Table 70. Teva Pharmaceutical Industries Corporation Information
Table 71. Teva Pharmaceutical Industries Description and Major Businesses
Table 72. Teva Pharmaceutical Industries Combined hormonal contraceptive Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Teva Pharmaceutical Industries Product
Table 74. Teva Pharmaceutical Industries Recent Development
Table 75. Bayer HealthCare Pharmaceuticals Corporation Information
Table 76. Bayer HealthCare Pharmaceuticals Description and Major Businesses
Table 77. Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bayer HealthCare Pharmaceuticals Product
Table 79. Bayer HealthCare Pharmaceuticals Recent Development
Table 80. Actavis Corporation Information
Table 81. Actavis Description and Major Businesses
Table 82. Actavis Combined hormonal contraceptive Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Actavis Product
Table 84. Actavis Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Major Businesses
Table 87. Pfizer Combined hormonal contraceptive Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Product
Table 89. Pfizer Recent Development
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Major Businesses
Table 92. Johnson & Johnson Combined hormonal contraceptive Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Johnson & Johnson Product
Table 94. Johnson & Johnson Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Major Businesses
Table 97. GlaxoSmithKline Combined hormonal contraceptive Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Watson Pharma Corporation Information
Table 101. Watson Pharma Description and Major Businesses
Table 102. Watson Pharma Combined hormonal contraceptive Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Watson Pharma Product
Table 104. Watson Pharma Recent Development
Table 105. Cipla Corporation Information
Table 106. Cipla Description and Major Businesses
Table 107. Cipla Combined hormonal contraceptive Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Cipla Product
Table 109. Cipla Recent Development
Table 110. Novartis International Corporation Information
Table 111. Novartis International Description and Major Businesses
Table 112. Novartis International Combined hormonal contraceptive Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Novartis International Product
Table 114. Novartis International Recent Development
Table 115. Global Combined hormonal contraceptive Sales Forecast by Regions (2021-2026) (K MT)
Table 116. Global Combined hormonal contraceptive Sales Market Share Forecast by Regions (2021-2026)
Table 117. Global Combined hormonal contraceptive Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 118. Global Combined hormonal contraceptive Revenue Market Share Forecast by Regions (2021-2026)
Table 119. North America: Combined hormonal contraceptive Sales Forecast by Country (2021-2026) (K MT)
Table 120. North America: Combined hormonal contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Europe: Combined hormonal contraceptive Sales Forecast by Country (2021-2026) (K MT)
Table 122. Europe: Combined hormonal contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Asia Pacific: Combined hormonal contraceptive Sales Forecast by Region (2021-2026) (K MT)
Table 124. Asia Pacific: Combined hormonal contraceptive Revenue Forecast by Region (2021-2026) (US$ Million)
Table 125. Latin America: Combined hormonal contraceptive Sales Forecast by Country (2021-2026) (K MT)
Table 126. Latin America: Combined hormonal contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Middle East and Africa: Combined hormonal contraceptive Sales Forecast by Country (2021-2026) (K MT)
Table 128. Middle East and Africa: Combined hormonal contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 130. Key Challenges
Table 131. Market Risks
Table 132. Main Points Interviewed from Key Combined hormonal contraceptive Players
Table 133. Combined hormonal contraceptive Customers List
Table 134. Combined hormonal contraceptive Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Combined hormonal contraceptive Product Picture
Figure 2. Global Combined hormonal contraceptive Sales Market Share by Type in 2020 & 2026
Figure 3. Pills Product Picture
Figure 4. Patch Product Picture
Figure 5. Ring Product Picture
Figure 6. Global Combined hormonal contraceptive Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. E-commerce
Figure 10. Others
Figure 11. Combined hormonal contraceptive Report Years Considered
Figure 12. Global Combined hormonal contraceptive Market Size 2015-2026 (US$ Million)
Figure 13. Global Combined hormonal contraceptive Sales 2015-2026 (K MT)
Figure 14. Global Combined hormonal contraceptive Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Combined hormonal contraceptive Sales Market Share by Region (2015-2020)
Figure 16. Global Combined hormonal contraceptive Sales Market Share by Region in 2019
Figure 17. Global Combined hormonal contraceptive Revenue Market Share by Region (2015-2020)
Figure 18. Global Combined hormonal contraceptive Revenue Market Share by Region in 2019
Figure 19. Global Combined hormonal contraceptive Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Combined hormonal contraceptive Revenue in 2019
Figure 21. Combined hormonal contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Combined hormonal contraceptive Sales Market Share by Type (2015-2020)
Figure 23. Global Combined hormonal contraceptive Sales Market Share by Type in 2019
Figure 24. Global Combined hormonal contraceptive Revenue Market Share by Type (2015-2020)
Figure 25. Global Combined hormonal contraceptive Revenue Market Share by Type in 2019
Figure 26. Global Combined hormonal contraceptive Market Share by Price Range (2015-2020)
Figure 27. Global Combined hormonal contraceptive Sales Market Share by Application (2015-2020)
Figure 28. Global Combined hormonal contraceptive Sales Market Share by Application in 2019
Figure 29. Global Combined hormonal contraceptive Revenue Market Share by Application (2015-2020)
Figure 30. Global Combined hormonal contraceptive Revenue Market Share by Application in 2019
Figure 31. North America Combined hormonal contraceptive Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Combined hormonal contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Combined hormonal contraceptive Sales Market Share by Country in 2019
Figure 34. North America Combined hormonal contraceptive Revenue Market Share by Country in 2019
Figure 35. U.S. Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Combined hormonal contraceptive Market Share by Type in 2019
Figure 40. North America Combined hormonal contraceptive Market Share by Application in 2019
Figure 41. Europe Combined hormonal contraceptive Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Combined hormonal contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Combined hormonal contraceptive Sales Market Share by Country in 2019
Figure 44. Europe Combined hormonal contraceptive Revenue Market Share by Country in 2019
Figure 45. Germany Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Combined hormonal contraceptive Market Share by Type in 2019
Figure 56. Europe Combined hormonal contraceptive Market Share by Application in 2019
Figure 57. Asia Pacific Combined hormonal contraceptive Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Combined hormonal contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Combined hormonal contraceptive Sales Market Share by Region in 2019
Figure 60. Asia Pacific Combined hormonal contraceptive Revenue Market Share by Region in 2019
Figure 61. China Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Combined hormonal contraceptive Market Share by Type in 2019
Figure 84. Asia Pacific Combined hormonal contraceptive Market Share by Application in 2019
Figure 85. Latin America Combined hormonal contraceptive Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Combined hormonal contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Combined hormonal contraceptive Sales Market Share by Country in 2019
Figure 88. Latin America Combined hormonal contraceptive Revenue Market Share by Country in 2019
Figure 89. Mexico Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Combined hormonal contraceptive Market Share by Type in 2019
Figure 96. Latin America Combined hormonal contraceptive Market Share by Application in 2019
Figure 97. Middle East and Africa Combined hormonal contraceptive Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Combined hormonal contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Combined hormonal contraceptive Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Combined hormonal contraceptive Revenue Market Share by Country in 2019
Figure 101. Turkey Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Combined hormonal contraceptive Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Combined hormonal contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Combined hormonal contraceptive Market Share by Type in 2019
Figure 108. Middle East and Africa Combined hormonal contraceptive Market Share by Application in 2019
Figure 109. North America Combined hormonal contraceptive Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Combined hormonal contraceptive Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Combined hormonal contraceptive Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Combined hormonal contraceptive Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Combined hormonal contraceptive Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Combined hormonal contraceptive Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Combined hormonal contraceptive Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Combined hormonal contraceptive Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Combined hormonal contraceptive Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Combined hormonal contraceptive Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
複合血管造影の世界市場（～2026年） Angiography is an X-ray imaging technique in which, contrasting agents are injected into the blood stream to visualize the blood vessels and help understand the abnormalities of blood vessels such as aneurysms and atherosclerosis. It is commonly used for diagnosing the heart diseases such as Coronar…- 避妊用スポンジの世界市場（～2026年） Contraceptive sponges are used to prevent pregnancy. Contraceptive sponges are made of polyurethane foam. These contraceptive foam contain spermicide chemical to prevent the movement of sperm. North America is biggest market for the contraceptive sponges and expected to continue to dominate over the…
- データセンター用熱電併給（CHP）システムの世界市場（～2026年） The institutional segment in the U.S. combined heat and power system for data center market is expected to gain 10 BPS during the assessment period.Colleges/universities are estimated to account for a major revenue share in the institutional segment in the U.S combined heat and power system for data…
- 局所避妊薬の世界市場（～2026年） Contraception is deliberate prevention of pregnancy by interfering with normal process of ovulation, fertilization and implantation through the use of barriers, drugs, medical devices or surgical techniques. Contraceptives are the drugs or devices which prevents pregnancy and sexually transmitted di…
- 避妊具の世界市場（～2026年） Contraceptives devices are a variety of products that are used for the prevention of an unwanted pregnancy.Whilst preventing unwanted pregnancies remain one of the key reasons why contraceptive devices are used, the other important function of a vast variety of contraceptive devices is to prevent th…